BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35201310)

  • 1. Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.
    Yunusa I; Gagne JJ; Yoshida K; Bykov K
    JAMA Netw Open; 2022 Feb; 5(2):e220194. PubMed ID: 35201310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study.
    Donneyong MM; Bykov K; Bosco-Levy P; Dong YH; Levin R; Gagne JJ
    BMJ; 2016 Sep; 354():i5014. PubMed ID: 27694571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serotoninergic antidepressants and opiate analgesics: a sometimes-painful association. A case report].
    Reich M; Lefebvre-Kuntz D
    Encephale; 2010 Jun; 36 Suppl 2():D119-23. PubMed ID: 20513454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic consequences of selective serotonin reuptake inhibitor use with drugs also metabolized by the cytochrome P-450 system.
    Ozminkowski RJ; Hylan TR; Melfi CA; Meneades LM; Crown WH; Croghan TW; Robinson RL
    Clin Ther; 1998; 20(4):780-96. PubMed ID: 9737837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
    Oskotsky T; Maric I; Tang A; Oskotsky B; Wong RJ; Aghaeepour N; Sirota M; Stevenson DK
    JAMA Netw Open; 2021 Nov; 4(11):e2133090. PubMed ID: 34779847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors.
    Bali V; Chatterjee S; Carnahan RM; Chen H; Johnson ML; Aparasu RR
    Psychiatr Serv; 2015 Dec; 66(12):1333-40. PubMed ID: 26234334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Concomitant Use of Warfarin and Selective Serotonin Reuptake Inhibitors: A Multidatabase Observational Cohort Study.
    Dong YH; Bykov K; Choudhry NK; Donneyong MM; Huybrechts KF; Levin R; Schneeweiss S; Gagne JJ
    J Clin Psychopharmacol; 2017 Apr; 37(2):200-209. PubMed ID: 28129313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals.
    Bushnell GA; Rynn MA; Gerhard T; Keyes KM; Hasin DS; Cerdá M; Nyandege A; Olfson M
    Addiction; 2024 Feb; 119(2):356-368. PubMed ID: 37816665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
    Khan NF; Bykov K; Barnett ML; Glynn RJ; Vine SM; Gagne JJ
    Neurology; 2022 Sep; 99(13):e1432-e1442. PubMed ID: 35835561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
    Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
    Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
    Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
    JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.
    Weiner SG; Hendricks MA; El Ibrahimi S; Ritter GA; Hallvik SE; Hildebran C; Weiss RD; Boyer EW; Flores DP; Nelson LS; Kreiner PW; Fischer MA
    PLoS One; 2022; 17(4):e0266561. PubMed ID: 35381052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression.
    Desai R; Park H; Brown JD; Mohandas R; Smith SM
    Pharmacotherapy; 2022 Jun; 42(6):472-482. PubMed ID: 35478186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.
    Binkhorst L; Mathijssen RH; van Herk-Sukel MP; Bannink M; Jager A; Wiemer EA; van Gelder T
    Breast Cancer Res Treat; 2013 Jun; 139(3):923-9. PubMed ID: 23760858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine.
    Bali V; Chatterjee S; Johnson ML; Chen H; Carnahan RM; Aparasu RR
    Pharmacotherapy; 2017 Mar; 37(3):287-296. PubMed ID: 28079266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.
    Esposito D; Wahl P; Daniel G; Stoto MA; Erder MH; Croghan TW
    Clin Ther; 2009 Mar; 31(3):644-56. PubMed ID: 19393855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin syndrome induced by fluvoxamine and oxycodone.
    Karunatilake H; Buckley NA
    Ann Pharmacother; 2006 Jan; 40(1):155-7. PubMed ID: 16368927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.